79759-89-0

Upstream product

• 162140-41-2 (5-chloro-2-nitro-phenyl)-(2-chloro-phenyl)-amine 
• 700-37-8 4-chloro-2-fluoro-nitrobenzene 
• 95-51-2 o-chloroaniline 

Downstream Products

• 79759-61-8 5-Chloro-3-(2-chloro-phenyl)-1-methyl-1,3-dihydro-benzoimidazol-2-one 
• 79759-60-7 5-chloro-3-(2-chlorophenyl)-1,3-dihydro-2H-benzimidazol-2-one 
• 79759-12-9 N¹-o.chlorophenyl-N²-carbethoxy-5-chloro-o.phenylenediamine 

Relevant academic research and scientific papers

A selective class of inhibitors for the CLC-Ka chloride ion channel

CLC proteins are a ubiquitously expressed family of chloride-selective ion channels and transporters. A dearth of pharmacological tools for modulating CLC gating and ion conduction limits investigations aimed at understanding CLC structure/function and ph

1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives

The present invention relates to 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives of the formula: STR1 to their preparation and to the pharmaceutical compositions in which they are present. These derivatives have an affinity for the vasopressin and oxytocin receptors.